58 results
Page 2 of 3
8-K
EX-3.1
hxgq3 drbxb40px
17 Dec 21
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-99.1
vsowlbm
24 Mar 21
Moleculin Biotech, Inc. Reports Financial Results
7:31am
424B5
83rpz6d3p2pussqktz
4 Feb 21
Prospectus supplement for primary offering
4:01pm
424B5
rwfrg
2 Feb 21
Prospectus supplement for primary offering
4:29pm
8-K
EX-99.1
nf9adh 3vr
2 Feb 21
Moleculin Announces 100% Survival Achieved in Osteosarcoma Lung Metastases Animal Model
7:29am
S-8
EX-4.4
5re35e4664jmyyo
21 Aug 20
Registration of securities for employees
4:31pm
8-K
EX-99.1
ehb7xts7t
25 Jun 20
Moleculin Announces Preclinical Data Confirms Efficacy of Annamycin in Lung Metastases
7:31am
8-K
EX-99.1
sf1kbny p20yn8wjsign
16 Mar 20
Regulation FD Disclosure
12:00am
424B5
y121wy8e
6 Feb 20
Prospectus supplement for primary offering
5:08pm
8-K
EX-99.1
5uwv74 kh6f2y8im
13 Jan 20
Regulation FD Disclosure
7:01am
8-K
EX-99.1
kdkp0o tnnuwotr5
29 Oct 19
Regulation FD Disclosure
4:01pm